These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 8652896

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Metabolic problems in recipients of liver transplants.
    Jindal RM, Sidner RA, Hughes D, Pescovitz MD, Leapman SB, Milgrom ML, Lumeng L, Filo RS.
    Clin Transplant; 1996 Apr; 10(2):213-7. PubMed ID: 8664522
    [Abstract] [Full Text] [Related]

  • 3. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
    Elmagd MM, Bakr MA, Metwally AH, Wahab AM.
    Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
    [Abstract] [Full Text] [Related]

  • 4. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
    Younes BS, McDiarmid SV, Martin MG, Vargas JH, Goss JA, Busuttil RW, Ament ME.
    Transplantation; 2000 Jul 15; 70(1):94-9. PubMed ID: 10919581
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporine A withdrawal during follow-up after pediatric liver transplantation.
    Scheenstra R, Torringa ML, Waalkens HJ, Middelveld EH, Peeters PM, Slooff MJ, Gouw AS, Verkade HJ, Bijleveld CM.
    Liver Transpl; 2006 Feb 15; 12(2):240-6. PubMed ID: 16447209
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct 15; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO, Price FW.
    Ophthalmology; 2006 Oct 15; 113(10):1785-90. PubMed ID: 16884779
    [Abstract] [Full Text] [Related]

  • 10. A long-term study on hyperlipidemia in stable renal transplant recipients.
    Tse KC, Lam MF, Yip PS, Li FK, Lai KN, Chan TM.
    Clin Transplant; 2004 Jun 15; 18(3):274-80. PubMed ID: 15142048
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov 15; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 13. The importance of early cyclosporine levels in pediatric kidney transplantation.
    Matas AJ, Gillingham KJ, Chavers BM, Nevins T, Kashtan C, Mauer SM, Payne WD, Gruessner R, Najarian JS.
    Clin Transplant; 1996 Dec 15; 10(6 Pt 1):482-6. PubMed ID: 8996767
    [Abstract] [Full Text] [Related]

  • 14. Long-term results with single pediatric donor kidney transplants in adult recipients.
    Modlin C, Novick AC, Goormastic M, Hodge E, Mastrioanni B, Myles J.
    J Urol; 1996 Sep 15; 156(3):890-5. PubMed ID: 8709356
    [Abstract] [Full Text] [Related]

  • 15. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
    Thervet E, Pfeffer P, Scolari MP, Toselli L, Pallardó LM, Chadban S, Pilmore H, Connolly J, Buchler M, Schena FP, Carreño CA, Dandavino R, Cole E.
    Transplantation; 2003 Sep 27; 76(6):903-8. PubMed ID: 14508352
    [Abstract] [Full Text] [Related]

  • 16. Analysis of rejection episodes in over 100 pediatric intestinal transplant recipients.
    Selvaggi G, Kato T, Gaynor JJ, Thompson J, Nishida S, Madariaga J, Levi D, Moon J, Ruiz P, Cantwell P, Tuteja S, Tzakis A.
    Transplant Proc; 2006 Sep 27; 38(6):1711-2. PubMed ID: 16908257
    [Abstract] [Full Text] [Related]

  • 17. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children.
    Salomon R, Gagnadoux MF, Niaudet P.
    Transplantation; 2003 Mar 27; 75(6):810-4. PubMed ID: 12660507
    [Abstract] [Full Text] [Related]

  • 18. Study of the renal function in nonrenal organ transplantation.
    Diez Ojea B, Gago González E, Díaz Corte C, Díaz Molina B, Dieguez L, Ortega Suárez F, Alvarez Grande J.
    Transplant Proc; 2006 Nov 27; 38(9):2985-8. PubMed ID: 17112881
    [Abstract] [Full Text] [Related]

  • 19. Outcome of renal transplants from pediatric donors <5 yr of age.
    El-Sabrout R, Buch K.
    Clin Transplant; 2005 Jun 27; 19(3):316-20. PubMed ID: 15877791
    [Abstract] [Full Text] [Related]

  • 20. Correlation of C0 and C2 levels with lipid profiles in adolescent renal transplant recipients in the early and late posttransplant periods.
    Soylu A, Kavukçu S, Türkmen MA, Kasap B, Soylu A, Bora S, Gülay H.
    Transplant Proc; 2006 Jun 27; 38(5):1286-9. PubMed ID: 16797283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.